344
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Comparative Analysis of Hyaluronidase-Mediated Degradation Among Seven Hyaluronic Acid Fillers in Hairless Mice

ORCID Icon, , , , ORCID Icon, , ORCID Icon & show all
Pages 241-248 | Published online: 08 Mar 2021

References

  • Fraser JR, Laurent TC, Laurent UB. Hyaluronan: its nature, distribution, functions and turnover. J Intern Med. 1997;242(1):27–33. doi:10.1046/j.1365-2796.1997.00170.x
  • Necas J, Bartosikova L, Brauner P, Kolar J. Hyaluronic acid (hyaluronan): a review. Vet Med-Czech. 2008;53(8):397–411. doi:10.17221/1930-VETMED
  • Holmstrom B, Ricica J. Production of hyaluronic acid by a streptococcal strain in batch culture. Appl Microbiol. 1967;15(6):1409–1413. doi:10.1128/AM.15.6.1409-1413.1967
  • Dicker KT, Gurski LA, Pradhan-Bhatt S, Witt RL, Farach-Carson MC, Jia X. Hyaluronan: a simple polysaccharide with diverse biological functions. Acta Biomater. 2014;10(4):1558–1570. doi:10.1016/j.actbio.2013.12.019
  • Kim JE, Sykes JM. Hyaluronic acid fillers: history and overview. Facial Plast Surg. 2011;27(6):523–528. doi:10.1055/s-0031-1298785
  • Beleznay K, Humphrey S, Carruthers JD, Carruthers A. Vascular compromise from soft tissue augmentation: experience with 12 cases and recommendations for optimal outcomes. J Clin Aesthet Dermatol. 2014;7(9):37–43.
  • Landau M. Hyaluronidase caveats in treating filler complications. Dermatol Surg. 2015;41(Suppl 1):S347–S353. doi:10.1097/DSS.0000000000000555
  • Csoka AB, Frost GI, Stern R. The six hyaluronidase-like genes in the human and mouse genomes. Matrix Biol. 2001;20(8):499–508. doi:10.1016/S0945-053X(01)00172-X
  • Chanmee T, Ontong P, Itano N. Hyaluronan: a modulator of the tumor microenvironment. Cancer Lett. 2016;375(1):20–30. doi:10.1016/j.canlet.2016.02.031
  • Menzinger S, Kaya A, Saurat JH, Kaya G. Injected hyaluronidase reduces the volume of exogenous hyaluronate fillers in mice and results in clinical improvement in a patient with pretibial myxedema. Dermatopathology (Basel). 2016;3(3):61–67. doi:10.1159/000446699
  • Buhren BA, Schrumpf H, Hoff NP, Bolke E, Hilton S, Gerber PA. Hyaluronidase: from clinical applications to molecular and cellular mechanisms. Eur J Med Res. 2016;21:5. doi:10.1186/s40001-016-0201-5
  • De Boulle K, Glogau R, Kono T, et al. A review of the metabolism of 1,4-butanediol diglycidyl ether-crosslinked hyaluronic acid dermal fillers. Dermatol Surg. 2013;39(12):1758–1766. doi:10.1111/dsu.12301
  • Gold MH. What’s New in Fillers in 2010? J Clin Aesthet Dermatol. 2010;3(8):36–45.
  • Shumate GT, Chopra R, Jones D, Messina DJ, Hee CK. In vivo degradation of crosslinked hyaluronic acid fillers by exogenous hyaluronidases. Dermatol Surg. 2018;44(8):1075–1083. doi:10.1097/DSS.0000000000001525
  • Bogdan Allemann I, Baumann L. Hyaluronic acid gel (JuvédermTM) preparations in the treatment of facial wrinkles and folds. Clin Interv Aging. 2008;3(4):629–634. doi:10.2147/CIA.S3118
  • Brandt FS, Cazzaniga A, Brandt F. Hyaluronic acid gel fillers in the management of facial aging. Clin Interv Aging. 2008;3(1):153–159. doi:10.2147/CIA.S2135
  • Paap MK, Silkiss RZ. The interaction between hyaluronidase and hyaluronic acid gel fillers - a review of the literature and comparative analysis. Plastic Aesthet Res. 2020;7:36.
  • Joo HJ, Woo YJ, Kim JE, Kim BJ, Kang H. A randomized clinical trial to evaluate the efficacy and safety of lidocaine-containing monophasic hyaluronic acid filler for nasolabial folds. Plast Reconstr Surg. 2016;137(3):799–808. doi:10.1097/01.prs.0000479965.14775.f0
  • Pak C, Park J, Hong J, Jeong J, Bang S, Heo CY. A phase III, randomized, multi-center, double-masked, matched-pairs, active-controlled trial to compare the efficacy and safety between neuramis deep and restylane in the correction of nasolabial folds. Arch Plast Surg. 2015;42(6):721–728. doi:10.5999/aps.2015.42.6.721
  • ISO 10993–6. Biological Evaluation of Medical Devices. Part 6: Tests for Local Effects After Implantation. International Organization for Standardization; 2016.
  • Betemps JB, Marchetti F, Lim T, et al. Projection capacity assessment of hyaluronic acid fillers. Plast Aesthet Res. 2018;5:19. doi:10.20517/2347-9264.2018.24
  • Yeom J, Bhang SH, Kim BS, et al. Effect of cross-linking reagents for hyaluronic acid hydrogel dermal fillers on tissue augmentation and regeneration. Bioconjug Chem. 2010;21(2):240–247. doi:10.1021/bc9002647
  • Dunn AL, Heavner JE, Racz G, Day M. Hyaluronidase: a review of approved formulations, indications and off-label use in chronic pain management. Expert Opin Biol Ther. 2010;10(1):127–131. doi:10.1517/14712590903490382
  • Jones D, Tezel A, Borrel M. In vitro resistance to degradation of hyaluronic acid dermal fillers by ovine testicular hyaluronidase. Dermatol Surg. 2010;36(1):804–809. doi:10.1111/j.1524-4725.2010.01550.x
  • Sall I, Ferard G. Comparison of the sensitivity of 11 crosslinked hyaluronic acid gels to bovine testis hyaluronidase. Polym Degrad Stabil. 2007;92(5):915–919. doi:10.1016/j.polymdegradstab.2006.11.020
  • Juhász ML, Levin MK, Marmur ES. The kinetics of reversible hyaluronic acid filler injection treated with hyaluronidase. Dermatol Surg. 2017;43(6):841–847. doi:10.1097/DSS.0000000000001084
  • Buhren BA, Schrumpf H, Bolke E, Kammers K, Gerber PA. Standardized in vitro analysis of the degradability of hyaluronic acid fillers by hyaluronidase. Eur J Med Res. 2018;23(1):37. doi:10.1186/s40001-018-0334-9
  • Girish KS, Kemparaju K. The magic glue hyaluronan and its eraser hyaluronidase: a biological overview. Life Sci. 2007;80(21):1921–1943.